Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$32,274,149
+$18,107,334 QoQ
Shares Held
395,662
+90.3% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#54
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Derivatives in PTCT

reported options exposure · as of Jun 30, 2026
CallValue
$5,000,241
CallShares
61,300
PutValue
$3,531,981
PutShares
43,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. PTCT ranks #14 (2.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 1,053,896 $140,442,180
2 CYTK
Cytokinetics Inc
 1,549,458 $131,998,327
3 REGN
Regeneron Pharmaceuticals, Inc.
 180,219 $112,373,755
4 ALNY
Alnylam Pharmaceuticals, Inc.
 294,460 $88,641,293
5 MDGL
Madrigal Pharmaceuticals, Inc.
 148,610 $79,796,139
6 INSM
INSMED Inc
 729,354 $77,763,723
7 VRTX
Vertex Pharmaceuticals Inc / Ma
 144,174 $71,615,550
8 AGIO
Agios Pharmaceuticals, Inc.
 1,375,558 $51,046,957

All Filings in PTCT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,000,241 61,300
2026-06-30 $3,531,981 43,300
2026-06-30 $32,274,149 395,662
2026-03-31 $5,661,603 83,100
2026-03-31 $4,898,547 71,900
2026-03-31 $14,166,815 207,938
2025-12-31 $9,814,032 129,200
2025-12-31 $9,776,052 128,700
2025-12-31 $1,419,008 18,681
2025-09-30 $2,414,909 39,350
2025-09-30 $7,640,565 124,500
2025-09-30 $13,482,989 219,700
2025-06-30 $3,335,772 68,300
2025-06-30 $6,969,468 142,700
2025-06-30 $21,085,693 431,730
2025-03-31 $5,405,174 106,067
2025-03-31 $8,810,984 172,900
2025-03-31 $5,717,712 112,200
2024-12-31 $5,922,368 131,200
2024-12-31 $4,589,338 101,669
2024-12-31 $9,398,148 208,200
2024-09-30 $278,250 7,500
2024-09-30 $821,468 22,142
2024-09-30 $2,003,400 54,000
2024-06-30 $494,937 16,185
2024-06-30 $2,247,630 73,500
2024-06-30 $2,544,256 83,200
2024-03-31 $1,554,394 53,434
2024-03-31 $450,895 15,500
2024-03-31 $1,023,968 35,200
2023-12-31 $674,282 24,466
2023-12-31 $1,008,696 36,600
2023-12-31 $418,912 15,200
2023-09-30 $318,222 14,200
2023-09-30 $1,541,808 68,800
2023-09-30 $2,184,121 97,462
2023-06-30 $935,410 23,000
2023-06-30 $4,669,159 114,806
2023-06-30 $4,071,067 100,100
2023-03-31 $678,160 14,000
2023-03-31 $5,926,585 122,349
2023-03-31 $406,896 8,400
2022-12-31 $2,206,226 57,800
2022-12-31 $2,084,082 54,600
2022-12-31 $1,644,172 43,075
2022-09-30 $2,013,020 40,100
2022-09-30 $3,925,640 78,200
2022-09-30 $3,564,501 71,006
2022-06-30 $472,708 11,800
2022-06-30 $2,131,071 53,197